Ranitidine Syrup
Product Images NDC 0121-0727

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 0121-0727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaceutical Associates, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ranitidine 01)

Chemical structure of Ranitidine, the active ingredient shown in the product image. The molecular diagram illustrates the arrangement of atoms and bonds characteristic of Ranitidine.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL (75 mg/5 mL) label showing it is an alcohol-free oral syrup in a 16 fl oz (473 mL) bottle. Contains 16.8 mg ranitidine hydrochloride equivalent per mL to 15 mg ranitidine. Rx only. Labeler is Pharmaceutical Associates, Inc., Greenville, SC. Storage instructions and usual dosage reference included.*

FDA Label Image

Principal Display Panel (10 mL Cup Lid)

Ranitidine Syrup label from Pharmaceutical Associates, Inc., Greenville, SC. The label shows an oral syrup dosage form with a strength of 150 mg/10 mL (equivalent to 15 mg/mL). The package contains 10 mL, and includes storage instructions and barcode information. It is for institutional use only and marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.